Quarter Financials
Keros Therapeutics, Inc. (KROS)
$49.15
-1.10 (-2.19%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -30 | -24 | -27 | -24 | -7 | -20 | -16 | -16 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -228 | -199 | -175 | -148 | -124 | -117 | -97 | -81 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -0 | -0 | -1 | -0 | -0 | -0 | -1 | -0 |
|---|
| Net PPE | 18 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|